HR3702

The Extreme Heat Economic Study Act of 2025 (HR3702) was introduced in the House on June 4, 2025, and subsequently referred to the House Committee on Energy and Commerce. This bill requires the Under Secretary of Commerce for Oceans and Atmosphere to conduct an economic impact study of the financial costs of extreme heat. The study is mandated to quantify the dollar value of loss of life and property, evaluate health impacts, property damage, medical assistance expenses, insurance claims (life, health, workers' compensation, business interruption, crop, livestock), labor productivity losses, and energy costs. This bill does not authorize or appropriate any specific funding amount. Its primary mechanism is to establish a policy directive for a federal study. The study's findings, however, are likely to create future demand for services related to climate risk assessment, data collection, and reporting. This could benefit firms specializing in environmental, social, and governance (ESG) consulting, data analytics, and insurance products designed to mitigate climate-related risks. The bill's early stage means it has a long legislative path ahead, but the existence of a companion bill (S1743) in the Senate indicates bipartisan and bicameral interest in the topic. Structural beneficiaries of this policy directive, should it advance, include consulting firms like Accenture ($ACN) that provide climate risk advisory services, and technology companies such as IBM ($IBM) that offer data analytics and AI solutions for complex data analysis. Financial services firms, particularly those in risk assessment and insurance, stand to benefit from increased demand for climate-related financial products and data. This includes credit rating agencies like Moody's ($MCO) and S&P Global ($SPGI), as well as insurance providers such as Aon ($AON), Chubb Limited ($CB), The Allstate Corporation ($ALL), The Travelers Companies, Inc. ($TRV), and Aflac Incorporated ($AFL), as the study will highlight the financial implications of extreme heat on their underwriting and claims processes. CME Group ($CME) is less directly impacted by this specific study, as it focuses on market data and derivatives, though broader climate risk awareness could eventually influence commodity markets. Looking at recent market data, IBM ($246.74) has seen a 4% increase over the last 7 days but a -3.82% decrease over the last 30 days. Accenture ($198.95) is up 0.71% in 7 days but down -7.03% in 30 days. Moody's ($444.1) is up 2.79% in 7 days but down -5.52% in 30 days. S&P Global ($434.11) is up 3.96% in 7 days but down -3.77% in 30 days. Aon ($326.17) is up 0.65% in 7 days but down -3.72% in 30 days. Chubb Limited ($326.9) is up 0.48% in 7 days but down -1.67% in 30 days. Allstate ($208.36) is up 0.53% in 7 days but down -1.54% in 30 days. Travelers ($295.55) is up 1.28% in 7 days but down -3.62% in 30 days. Aflac ($110.26) is up 1.93% in 7 days but down -0.7% in 30 days. CME Group ($308.57) is up 3.69% in 7 days but down -2.6% in 30 days. The recent 7-day increases across most of these firms suggest a general positive market sentiment in the very short term, despite broader 30-day declines. Legislative steps remaining for HR3702 include committee consideration, potential markups, and a vote in the House. If passed by the House, it would then move to the Senate for similar consideration. The presence of a companion bill, S1743, suggests a coordinated effort, which could expedite the process if both chambers prioritize the issue. However, the bill is still in its initial stages, and passage is not guaranteed.